Braze, Inc.: Form 10-Q for the period ended Oct 31, 2025
Filed with the SEC on Dec 10, 2025 and accepted by EDGAR at Dec 9, 2025, 17:42 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-08-01 to 2025-10-31 | $190.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-02-01 to 2025-10-31 | $533.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-08-01 to 2025-10-31 | $62.6m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2025-02-01 to 2025-10-31 | $171.7m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2025-08-01 to 2025-10-31 | $128.2m | us-gaap:GrossProfit |
| Gross profit | 9 months2025-02-01 to 2025-10-31 | $361.3m | us-gaap:GrossProfit |
| Research and development | 3 months2025-08-01 to 2025-10-31 | $44.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2025-02-01 to 2025-10-31 | $122.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-08-01 to 2025-10-31 | −$37.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-02-01 to 2025-10-31 | −$116.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-08-01 to 2025-10-31 | $1.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-02-01 to 2025-10-31 | −$4.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-08-01 to 2025-10-31 | −$36.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-02-01 to 2025-10-31 | −$99.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-08-01 to 2025-10-31 | −$0.33 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-02-01 to 2025-10-31 | −$0.93 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-08-01 to 2025-10-31 | −$0.33 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-02-01 to 2025-10-31 | −$0.93 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-08-01 to 2025-10-31 | 107,627,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-02-01 to 2025-10-31 | 107,035,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-02-01 to 2025-10-31 | $52.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-02-01 to 2025-10-31 | $4.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-10-31 | $97.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-10-31 | $502.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-10-31 | $1.04bn | us-gaap:Assets |
| Current liabilities | At period end2025-10-31 | $369.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-10-31 | $438.9m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-10-31 | $602.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001676238-25-000147. Last ingested by Listed: Oct 29, 2026, 16:22 ET. Listed shows no prices and gives no investment advice.